Huimin Lin
Fujian Provincial People's Hospital(CN)
Publications by Year
Research Areas
Mast cells and histamine, Eosinophilic Disorders and Syndromes, Lymphoma Diagnosis and Treatment, Cutaneous lymphoproliferative disorders research, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial(2017)569 cited
- → Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition(2003)242 cited
- → Self-Amplification of Tumor Oxidative Stress with Degradable Metallic Complexes for Synergistic Cascade Tumor Therapy(2020)227 cited
- → Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial(2021)141 cited
- → Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model(2003)139 cited
- → Cell-Mediated Autophagy Promotes Cancer Cell Survival(2012)138 cited
- → Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial(2021)137 cited
- → Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model(2004)121 cited
- → SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10(2005)100 cited
- → Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates(2004)100 cited